Heart-Lung Machine Lifecycle Planning: When to Repair vs. Replace

Capital decisions around perfusion equipment are rarely straightforward. This analysis provides a framework for evaluating total cost of ownership and timing replacement decisions to minimize disruption and cost.

Gary Plancher, CCP, MHA

Founder & Principal Consultant, Gate Medicals

The heart-lung machine sits at the center of every cardiac surgery program, and decisions about its maintenance, repair, and replacement carry significant clinical, operational, and financial weight. Despite this, most hospitals approach these decisions reactively — replacing equipment after a crisis rather than on a plan, and managing repair decisions case-by-case rather than against a lifecycle framework.

The Total Cost of Ownership Problem

Capital equipment decisions are frequently evaluated on purchase price alone, which systematically undervalues the cost of an aging equipment fleet. A heart-lung machine that is fully depreciated on the books but requires frequent service calls, has components that are no longer supported by the manufacturer, or is incompatible with current disposables and monitoring integrations, is not a free asset — it is a liability with an invisible ongoing cost.

True total cost of ownership for perfusion equipment should include: acquisition cost (purchase or lease), annual maintenance agreement cost, unplanned repair frequency and cost, downtime impact on case scheduling, disposable compatibility costs (older platforms often require more expensive or less efficient circuit configurations), and staff training cost associated with platform-specific operation.

Indicators That Favor Replacement

Indicators That Favor Continued Repair

The Timing Question

When replacement is indicated, timing matters significantly. Equipment replacement should be planned to coincide with: capital budget cycles that allow for full funding approval without emergency supplemental requests; low-volume surgical periods that accommodate staff training without schedule disruption; and contract negotiation windows that allow the new equipment to be considered as part of a comprehensive supply and service agreement.

Poorly timed replacements — driven by unexpected equipment failure rather than planned lifecycle management — routinely cost 20–30% more than planned replacements, both in capital cost (less time to negotiate) and in operational disruption (emergency rental equipment, expedited training, schedule compression).

Building a Lifecycle Plan

Every cardiac surgery program should maintain a five-year capital equipment lifecycle plan for perfusion equipment, updated annually. The plan should inventory all current equipment with purchase date, current maintenance status, manufacturer support status, and estimated remaining useful life. It should project replacement needs and costs over the planning period, identify options (purchase, lease, bundled vendor arrangement) for each replacement event, and integrate with the institution's broader capital planning process.

Programs that manage equipment this way consistently spend less — not because they make different individual decisions, but because they make those decisions with more information, more time, and more negotiating leverage than programs that react to equipment failure when it occurs.

Ready to take a closer look at your program?

Gate Medicals offers a complimentary preliminary assessment for cardiovascular perfusion programs nationwide. No commitment required.